Averna Therapeutics
PrivateLast Round
Series A
Jun 25, 2024
Total Funding Raised
$82M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Averna Therapeutics is a biotechnology company that develops RNA/lipid nanoparticle-based genomic medicines to durably and safely treat a broad range of diseases, including genetic disorders, cancer, and autoimmune conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Averna Therapeutics Comparables
Compare Averna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stylus Medicine | 81% | |
| Ensoma | 80% | |
| Tessera Therapeutics | 79% | |
Averna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 25, 2024 |
Averna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Insight | Series A |
| Innovation Endeavors | Series A |
| OrbiMed | Series A, Seed |
| Invus Opportunities | Series A |
| Arc Ventures | Series A |
| Delos Capital Partners | Series A |
| Invus | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 28, 2.3x the trailing average.
- Jul 24, 2026
Monthly visitors increased 390% MoM, reaching 7.7K.
Averna Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Averna Therapeutics's valuation, stock price, and market status.